Our sector experience
USD 50 billion
Advised Johnson & Johnson on the spin-off of its consumer products business, Kenvue, the deal spanning over 65 jurisdictions.
Johnson & Johnson
CASE STUDY
READ MORE
GlaxoSmithKline GBP 30 billion
Advised on the spin-off of its consumer healthcare business from the GSK Group to form Haleon plc, an independent listed company.
Perrigo
Advised on the sale of its Hospital & Specialty Products Business (H&S) in Australia and New Zealand to Genesis Capital.
Galvanize Nutrition
Advised on the divestment of its food supplement business, selling 85% of Galvanize Nutrition Kft. in Hungary and Swiss IP assets to Active Nutrition Group Zrt.
Read More